BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16129522)

  • 1. [Painful muscular hypertrophy].
    Grasland A; Grossin M; Vinceneux P
    Rev Med Interne; 2006 Mar; 27(3):255-6. PubMed ID: 16129522
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertrophic myopathy due to muscular metastasis of a signet cell adenocarcinoma of the bladder].
    Brénuchon C; Launay D; Maurage CA; Queyrel V; Lambert M; N'Guyen HD; Boutry N; Hachulla E; Hatron PY; Devulder B
    Rev Med Interne; 2004 Nov; 25(11):839-41. PubMed ID: 15501357
    [No Abstract]   [Full Text] [Related]  

  • 3. Skeletal muscle metastasis mimicking a shoulder effusion.
    Journeay WS; Omar A; Carette S
    J Rheumatol; 2013 Sep; 40(9):1616. PubMed ID: 23996995
    [No Abstract]   [Full Text] [Related]  

  • 4. Skeletal muscle metastasis from carcinoma of the bladder.
    Ekici S; Ozen H; Gedikoglu G; Aygün C
    Scand J Urol Nephrol; 1999 Oct; 33(5):336-7. PubMed ID: 10573000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer.
    Raj GV; Karavadia S; Schlomer B; Arriaga Y; Lotan Y; Sagalowsky A; Frenkel E
    Cancer; 2011 Jan; 117(2):276-82. PubMed ID: 20830767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gluteal muscular and sciatic nerve metastases in advanced urinary bladder carcinoma: case report.
    Nagao E; Nishie A; Yoshimitsu K; Irie H; Shioyama Y; Naito S; Matsuura S; Honda H
    Abdom Imaging; 2004; 29(5):619-22. PubMed ID: 15162230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of metastatic transitional cell carcinoma in response to tamoxifen.
    Dellagrammaticas D; Bryden AA; Collins GN
    J Urol; 2001 May; 165(5):1631. PubMed ID: 11342939
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiation therapy and concomitant paclitaxel/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: a well-tolerated combination.
    Nichols RC; Sweetser MG; Mahmood SK; Malamud FC; Dunn NP; Adams JP; Kyker JS; Lydick K
    Int J Cancer; 2000 Oct; 90(5):281-6. PubMed ID: 11091352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle metastasis in a case of bronchogenic carcinoma.
    Roy PP; Basu N; Basu AK
    J Indian Med Assoc; 2008 Apr; 106(4):256. PubMed ID: 18828348
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic options and treatment of muscle invasive bladder cancer.
    O'Connor RC; Alsikafi NF; Steinberg GD
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):511-22. PubMed ID: 12113083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for bladder cancer.
    Sonpavde G; Lerner SP
    Oncology (Williston Park); 2007 Dec; 21(14):1673-81; discussion 1686-8, 1691, 1694. PubMed ID: 18247016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for the treatment of muscle-invasive bladder cancer: argument in favor.
    Gallagher DJ; Bajorin DF
    Nat Clin Pract Urol; 2008 Sep; 5(9):484-5. PubMed ID: 18626513
    [No Abstract]   [Full Text] [Related]  

  • 13. Enlarged extraocular muscles from metastatic signet ring carcinoma.
    Loes L; Wesley RE; Lavin P
    Ophthalmic Surg Lasers; 1996 Jul; 27(7):632-5. PubMed ID: 9240782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer.
    Clark PE
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):821-30. PubMed ID: 19496719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung cancer and skeletal muscle metastases.
    Di Giorgio A; Sammartino P; Cardini CL; Al Mansour M; Accarpio F; Sibio S; Di Seri M
    Ann Thorac Surg; 2004 Aug; 78(2):709-11. PubMed ID: 15276559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of bone morphogenetic protein 2 in heterotopic ossification in metastatic lesion from urothelial carcinoma of bladder.
    Komai Y; Morimoto S; Saito K; Urushibara M; Sakai K; Ikeda S
    Int J Urol; 2006 Aug; 13(8):1126-8. PubMed ID: 16903944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer.
    Meeks JJ; Taylor JM; Matsushita K; Herr HW; Donat SM; Bochner BH; Dalbagni G
    BJU Int; 2013 Jun; 111(8):E325-30. PubMed ID: 23384236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy.
    Gilbert SM; Lee CT
    Nat Clin Pract Urol; 2006 Dec; 3(12):675-9. PubMed ID: 17149384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.
    Hahn NM; Knudsen BS; Daneshmand S; Koch MO; Bihrle R; Foster RS; Gardner TA; Cheng L; Liu Z; Breen T; Fleming MT; Lance R; Corless CL; Alva AS; Shen SS; Huang F; Gertych A; Gallick GE; Mallick J; Ryan C; Galsky MD; Lerner SP; Posadas EM; Sonpavde G
    Urol Oncol; 2016 Jan; 34(1):4.e11-7. PubMed ID: 26362343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Skeletal muscle metastases from non small cell lung].
    Faure E; Le Pimpec-Barthes F; Dusser D; Riquet M
    Rev Mal Respir; 2002 Feb; 19(1):93-5. PubMed ID: 17546820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.